Quisinostat HCl is an inhibitor of histone deacetylase (HDAC) enzymes. HDAC inhibitors focus on HDAC enzymes, hindering the growth of cancer cells and triggering apoptosis, the programmed death of cancer cells. It also disrupts the HAT-dependent transcriptional repression complex in the nucleus to promote expression of genes involved in cellular proliferation. Reagent grade, for research purpose.
Usually ships within 24 hours.